This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita, Alonzo Mourning, George Lopez Team Up To Raise Kidney Disease Awareness In Public Service Announcement

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the launch of a national television public service announcement (PSA) to raise awareness on the risks of kidney disease. March marks National Kidney Month, and March 14 is World Kidney Day.

The announcement features seven-time NBA All-star Alonzo Mourning and actor and comedian George Lopez, both kidney transplant recipients.

“The fact is, one in 10 adults* in the U.S. has kidney disease,” says Lopez in the announcement. “And it often has no symptoms, so know your risk.”

The leading causes of kidney disease are diabetes and hypertension. African-Americans are also four times more likely to suffer from chronic kidney disease than their white counterparts, and Hispanics are twice as likely. The risks for minorities are especially great, Mourning notes in the PSA.

“A simple blood test may save your kidneys,” Mourning concludes.

A risk assessment quiz is available online at The site also encourages those with risk factors to take a pledge to get tested and to send electronic cards to friends and family to encourage them to take the risk assessment.

“At DaVita, we see the challenges of kidney failure every day in our patients’ lives,” said Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners. “This announcement is designed to get everyone thinking about kidney disease, learning their risks, and then – if they are at risk – getting a simple blood test to screen for kidney disease.”

DaVita will also be launching a Denver-area kidney disease awareness campaign to help make its headquarters city the most kidney aware city in the U.S. The campaign will include daytime and primetime airings of the national PSA as well as transit advertising and a variety of public events throughout the year.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%
TSLA $247.54 -0.07%
YHOO $36.59 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs